Description
Epclusa (Sofosbuvir/Velpatasvir) 400mg/100mg Online
Epclusa (Sofosbuvir/Velpatasvir) is an antiviral medication that prevents the hepatitis C virus (HCV) from multiplying in your body. Epclusa is a combination medicine used to treat chronic hepatitis C in adults with HCV genotype 1, 2, 3, 4, 5, or 6. This medicine is given in combination with another antiviral medicine called ribavirin in people who also have advanced cirrhosis. Chronic hepatitis C: Treatment of chronic hepatitis C (CHC) genotype 1, 2, 3, 4, 5, or 6 infections in adults and pediatric patients ≥6 years of age or weighing ≥17 kg without cirrhosis or with compensated cirrhosis or in combination with ribavirin in patients with decompensated cirrhosis.
The combination of sofosbuvir and velpatasvir is used alone or with ribavirin (Copegus, Rebetol, Ribasphere) to treat chronic hepatitis C (an ongoing viral infection that damages the liver) in adults and children 6 years of age and older or who weigh at least 37 lbs (17 kg). Sofosbuvir is in a class of antiviral medications called nucleotide hepatitis C virus (HCV) NS5B polymerase inhibitors. Velpatasvir is in a class of antiviral medications called HCV NS5A replication complex inhibitors. The combination of sofosbuvir and velpatasvir works by stopping the virus that causes hepatitis C from spreading inside the body.
The combination of sofosbuvir and velpatasvir comes as a tablet to take by mouth. It is taken usually with or without food once a day for 12 weeks. Take sofosbuvir and velpatasvir at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take sofosbuvir and velpatasvir exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.
